Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
11/2005
11/10/2005WO2005105723A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005WO2005105065A2 Thiazole-based nitric oxide donors for treating inflammatory bowel diseases
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250824 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250820 Therapeutic modulation of PPARgamma activity
11/10/2005US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/10/2005US20050250786 PNA monomer and precursor
11/10/2005US20050250785 PNA monomer and precursor
11/10/2005US20050250777 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
11/10/2005US20050250776 ethyl (2-{[(2,4-dichloro-5-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetate; treatment of diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, without causing hypoglycemia
11/10/2005US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050250152 fluorescent derivatization reagents that label substances containing aldehydes, ketones, and similar functional groups, and their use in labeling glycoproteins and glycopeptides, nucleic acids and lipopolysaccharides, and other biomolecules
11/10/2005CA2566369A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2563443A1 Therapeutic formulations of desoxyepothilones
11/10/2005CA2555862A1 Polyamine analogs that activate antizyme frameshifting
11/09/2005EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
11/09/2005EP1593307A2 Agents for combatting plant pests
11/09/2005EP1592403A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1411935A4 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1019389B1 Epothilone derivatives
11/09/2005EP0873326B1 Process for preparing 2-chlorothiazole compounds
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
11/09/2005CN1226294C Fused heteroaromatic glucokinase activators
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/08/2005US6963000 Benzothiazole derivatives with activity as adenosine receptor ligands
11/08/2005US6962935 Anticoagulants; thrombosis therapy; cardiovascular disorders
11/08/2005CA2373834C A process for the production of thiazolidine
11/08/2005CA2256085C Association of procysteine with a polyol
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103022A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
11/03/2005WO2005103021A1 Tri(cyclo) substituted amide compounds
11/03/2005WO2005103013A1 Therapeutic agent for nonviral hepatitis
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005WO2004099165A3 Heterocyclic compounds and hydro isomers thereof
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245579 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
11/03/2005US20050245573 N-substituted benzene sulfonamides
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245432 N-methyl amino acids
11/03/2005CA2563192A1 Tri(cyclo) substituted amide compounds
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590337A1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
11/02/2005EP1589967A1 Benzthiazole-3 oxides useful for the treatment of proliferative disorders
11/02/2005EP1507530B1 Diaminothiazoles and use thereof as cdk4 inhibitors
11/02/2005EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
11/02/2005EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005EP0946531B1 Process for the preparation of thiazole derivatives
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1690051A Novel azoles having an insecticidal action
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/02/2005CN1225462C New piperazine and piperidine compounds
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960664 Aza hydroxylated ethyl amine compounds
11/01/2005US6960606 Adamantyl Thiazole Thioureas
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960604 Thyroid receptor ligands
11/01/2005US6960591 Propane-1,3-dione derivative
10/2005
10/27/2005WO2005100332A1 Dat1
10/27/2005WO2005100331A2 Antidiabetic agents
10/27/2005WO2005100330A1 Preparation of intermediate for 3-[2-(4-methylthiazole-5-yl)vinyl] cephalosporins
10/27/2005WO2005100329A1 Novel protecting reagents, protecting groups and methods of forming and using the same
10/27/2005WO2005100318A1 Alkanoic acids and their esters as antidiabetic agents
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
10/27/2005WO2005090295A3 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239853 New compounds
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239839 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/27/2005US20050239691 Cross-linked glycopeptide - cephalosporin antibiotics
10/27/2005US20050238677 Multi-lamellar liquid crystal emulsion system
10/27/2005US20050238614 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
10/27/2005DE102004016845A1 Phenylthioessigsäure-Derivate und ihre Verwendung Phenylthioacetic acid derivatives and their use
10/26/2005EP1589017A2 12,13-modified epothilone derivatives
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents
10/26/2005EP1587800A1 Thiazole derivatives and their use as vap-1 inhibitors
10/26/2005EP1587547A2 Amyloid-binding, metal-chelating agents
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 337